SPINFREE TAB

1. Specifications & All Details
Batch Number (B.No.): N2401470
Manufacturing Date (MFD.): JUN.2024
Expiry Date (EXP.): MAY 2026
Maximum Retail Price (M.R.P.): Rs. 210.00 per 15 tablets (Inclusive of all taxes)
Drug Classification Status: SCHEDULE H PRESCRIPTION DRUG – CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
Manufacturing License Number (Mfg. Lic. No.): M/717/2016
Internal Manufacturing Identifiers: 92 1544 3 9406132
Traceability Feature: Features printed square QR matrix codes on the metallic surface for batch identification and compliance verification.
2. General Information
Brand Name: Spinfree (स्पिनफ्री)
Generic Name: Cinnarizine & Dimenhydrinate Tablets
Product Type: Prescription anti-vertigo / vestibular therapeutic combination medication
Form Factor: Solid, oral uncoated tablets
Quantity: 15 Tablets per strip (indicated by the stamp text “FOR 15 TABS.”)
Maximum Shelf Life: 23 Months (From June 2024 to May 2026)
Food Preference & FSSAI: Not Applicable. This is a medicinal pharmaceutical formulation regulated under national drug authorities rather than a food supplement or nutraceutical product, meaning it does not feature an FSSAI layout or food item labels.
3. Product Details (Ingredients)
Each uncoated tablet contains:
Cinnarizine IP: 20 mg
Dimenhydrinate BP: 40 mg
Colouring Agents: Lake of Quinoline Yellow
Excipients: q.s. (Quantity Sufficient)
4. Directions & Storage
How to Use / Dosage: As directed by the Physician.
Storage Instructions: Store in a cool, dry & dark place below 25°C.
General Safety Guidance: Keep out of reach of children.
5. Description
Product Overview: Spinfree is a targeted prescription combination therapy featuring 20 mg of Cinnarizine (a calcium channel antagonist) and 40 mg of Dimenhydrinate (an antihistamine). Together, these active components synergize to address symptoms associated with balance disruptions, motion sickness, and vertigo disorders.
Visual Appearance: The primary packaging utilizes an Alu-Alu (aluminum-aluminum) silver foil blister layout with a distinctive micro-dimpled surface texture. The textual specifications are rendered cleanly using contrasting black and deep purple fonts. A bold red rectangular box runs through the center to emphasize its restricted Schedule H prescription status. Commercial pricing, batching details, and dates are stamped in violet-blue ink on the left-hand margin.
6. Manufacturer Information
Manufactured By: INTAS PHARMACEUTICALS LTD.
Plant Address: Samardung Road, Kabrey Block, Namthang Elaka, Sikkim-737132, INDIA.
7. Marketed By
Marketed By: Intas Pharmaceuticals Ltd.